References
- Bandyk D.F., T.M. Bergamini, E.V. Kinney, G.R. Seabrook and J.B. Towne. 1991. In situ replacement of vascular prostheses infected by bacterial biofilms. J. Vasc. Surg. 13: 575–583.
-
Batt M., E. Jean-Baptiste, S. O’Connor, P.J. Bouillanne, P. Haude- bourg, R. Hassen-Khodja, S. Declemy and R. Farhad. 2008. In situ
revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts. Eur. J. Vasc. Endovasc. Surg. 362: 182–188.
- Bronk M. and A. Samet. 2008. Hospital enterococcal bacteremias. Post. Mikrobiol. 47: 339–344.
- Budtz-Lilly J., N. Eldrup, S. Vammen and J. Laustsen. 2014. Femoral vein repair of arterial infections: technical tips to reduce procedure time. Vasc. Endovascular Surg. 48: 367–371.
- Dirven M., M.F. van der Jagt, W.B. Barendregt and D. van der Vliet. 2015. The efficacy of autologous femoropopliteal vein reconstruction for primary aortic and aortic graft infection. Ann. Vasc. Surg. 29: 1188–1195.
- Dünschede F., J. Stabrauskaite, G. Weisser, C. Espinola-Klein, B. Dorweiler and C.F. Vahl. 2015. Crural bypass for critical lower limb ischemia with Omniflow II prosthesis. Thorac. Cardiovasc. Surg. 64: 311–315.
- Fellmer P.T., G. Wiltberger, H.M. Tautenhahn, I. Matia, F. Kren- zien and S. Jonas. 2014. Early results after peripheral vascular replacement with biosynthetic collagen prosthesis in cases of graft infection (in German). Zentralbl Chir. 139: 546–551.
- Krasznai A.G., M. Snoeijs, M.P. Siroen, T. Sigterman, A. Kor- sten, F.L. Moll and L.H. Bouwman. 2015. Treatment of aortic graft infection by in situ reconstruction with Omniflow II biosynthetic prosthesis. Vascular. DOI: 10.1177/1708538115621195.
- Lew W. and W. Moore. 2011. Antibiotic-impregnated grafts for aortic reconstruction. Semin. Vasc. Surg. 244: 211–219.
- Neufang A., B. Dorweiler, C. Espinola-Klein, S. Savvidis, M. Doem- land, S. Schotten and C.F. Vahl. 2014. Outcomes of complex femo- rodistal sequential autologous vein and biologic prosthesis composite bypass grafts. J. Vasc. Surg. 60: 1543–1553.
- Palumbo R., P. Niscola, S. Calabria, S. Fierimonte, M. Bevilacqua, L. Scaramucci, B. Tolu, P. de Fabritiis and F. Bondanini. 2009. Long-term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis. Nephron. Clin. Pract. 1132: 76–80.
- Pupka A., B. Dolińska-Krajewska, S. Pawłowski and P. Szyber. 2004. Immunosuppression in the transplantation of the fresh arterial homograft – case report. Adv. Clin. Exp. Med. 13: 371–374.
- Samson R.H., F.J. Veith, G.S. Janko, S.K. Gupta and L.A. Scher. 1988. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J. Vasc. Surg. 8: 147–53.
- Seabroock G.R. 1990. Pathobiology of graft infections. Sem. Vasc. Surg. 3: 81–88.
- Swain T.W., K.D. Calligaro and M.D. Dougherty. 2004. Management of infected aortic prosthetic grafts. Vasc. Endovascular Surg. 38: 75–82.
- Töpel I., T. Betz, C. Uhl, M. Wiesner, S. Bröckner and M. Stein- bauer. 2012. Use of biosynthetic prosthesis (Omniflow II) to replace infected infrainguinal prosthetic grafts – first results. Vasa. 413: 215–220.
- Verhelst R., V. Lacroix and H. Vraux. 2000. Use of cryopreserved arterial homografts for mamagement of infected prosthetic grafts: a multicentric study. Ann. Vasc. Surg. 14: 602–607.
- Werkmeister J.A., J.F. White, G.A. Edwards and J.A. Ramshaw. 1995. Early performance appraisal of the Omniflow II vascular prosthesis as an indicator of long-term function. J. Long Term. Eff. Med. Implants. 5: 1–10.
- Wiltberger G., I. Matia, M. Schmelzle, F. Krenzien, H.M. Hau, B. Freitas, S. Jonas and P.T. Fellmer. 2014. Mid- and long-term results after replacement of infected peripheral vascular prosthetic grafts with biosynthetic collagen prosthesis. J. Cardiovasc. Surg. 55: 693–698.